Cargando…
Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein
The current coronavirus disease 2019 (COVID-19) vaccines are used to prevent viral infection by inducing neutralizing antibody in the body, but according to the existing experience of severe acute respiratory syndrome coronavirus (SARS) infection, T-cell immunity could provide a longer durable prote...
Autores principales: | Zhang, Yunwen, Yang, Zhengrong, Tang, Mingyuan, Li, Hao, Tang, Tian, Li, Guilian, Zhong, Yifan, Zhang, Xiaomin, Wang, Xiaohui, Wang, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831549/ https://www.ncbi.nlm.nih.gov/pubmed/35154095 http://dx.doi.org/10.3389/fimmu.2022.752622 |
Ejemplares similares
-
A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients
por: Zhang, Yunwen, et al.
Publicado: (2021) -
Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021) -
Seropositive Reaction Rates of 9 B-Cell Epitopes of the SARS-CoV-2 Spike Protein and the Relationship between the Epitopes and Neutralizing Antibody
por: Zhu, Li, et al.
Publicado: (2021) -
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021) -
Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
por: Hong, Junping, et al.
Publicado: (2021)